Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Quantitative proteomics of synaptosome S-nitrosylation in Alzheimer's disease.

Journal of neurochemistry | 2020

Increasing evidence suggests that both synaptic loss and neuroinflammation constitute early pathologic hallmarks of Alzheimer's disease. A downstream event during inflammatory activation of microglia and astrocytes is the induction of nitric oxide synthase type 2, resulting in an increased release of nitric oxide and the post-translational S-nitrosylation of protein cysteine residues. Both early events, inflammation and synaptic dysfunction, could be connected if this excess nitrosylation occurs on synaptic proteins. In the long term, such changes could provide new insight into patho-mechanisms as well as biomarker candidates from the early stages of disease progression. This study investigated S-nitrosylation in synaptosomal proteins isolated from APP/PS1 model mice in comparison to wild type and NOS2-/- mice, as well as human control, mild cognitive impairment and Alzheimer's disease brain tissues. Proteomics data were obtained using an established protocol utilizing an isobaric mass tag method, followed by nanocapillary high performance liquid chromatography tandem mass spectrometry. Statistical analysis identified the S-nitrosylation sites most likely derived from an increase in nitric oxide (NO) in dependence of presence of AD pathology, age and the key enzyme NOS2. The resulting list of candidate proteins is discussed considering function, previous findings in the context of neurodegeneration, and the potential for further validation studies.

Pubmed ID: 31520481 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Lamin B1 antibody (antibody)

RRID:AB_11232208

This monoclonal targets Lamin B1

View all literature mentions

alpha Tubulin Monoclonal Antibody (DM1A) (antibody)

RRID:AB_1965960

This monoclonal targets alpha Tubulin

View all literature mentions

Anti-NMDAR2B (antibody)

RRID:AB_11214394

This polyclonal targets NMDAR2B

View all literature mentions

Synaptophysin antibody [EP1098Y] (antibody)

RRID:AB_882786

This monoclonal targets Synaptophysin

View all literature mentions

Anti-Glutamate receptor 1 (antibody)

RRID:AB_2113602

This polyclonal targets Glutamate receptor 1

View all literature mentions

B6.129P2-Nos2tm1Lau/J (organism)

RRID:IMSR_JAX:002609

Mus musculus with name B6.129P2-Nos2tm1Lau/J from IMSR.

View all literature mentions

C57BL/6J (organism)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions